December 5, 2019 / 7:12 PM / a month ago

BRIEF-FDA Authorizes Roche Molecular Systems' cobas vivoDx MRSA Diagnostic Test

Dec 5 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA - AUTHORIZED MARKETING OF NEW DIAGNOSTIC TEST TO DETECT METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BACTERIAL COLONIZATION

* FDA SAYS GRANTED MARKETING AUTHORIZATION OF NEW NEW DIAGNOSTIC TEST, CALLED COBAS VIVODX MRSA TEST, TO ROCHE MOLECULAR SYSTEMS INC. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below